Rheumatoid arthritis-related interstitial lung disease: Associations, prognostic factors and physiological and radiological characteristics-a large multicentre UK study

Rheumatology (United Kingdom)

Volumn 53, Issue 9, 2014, Pages 1676-1682

  Kelly, Clive A ^a   Saravanan, Vadivelu ^a   Nisar, Mohamed ^b   Arthanari, Subha ^b   Woodhead, Felix A ^c   Price Forbes, Alec N ^c   Dawson, Julie ^d   Sathi, Navtej ^e   Ahmad, Yasmeen ^f   Koduri, Gouri ^g   Young, Adam ^g  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b DERBY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c Coventry and Warwickshire Hospital ^*  (United Kingdom)

^d St Helens Hospital   (United Kingdom)

^e WRIGHTINGTON HOSPITAL   (United Kingdom)

^f BETSI CADWALADR UNIVERSITY HEALTH BOARD   (United Kingdom)

^g St Albans City Hospital   (United Kingdom)

Author keywords

High resolution computed tomography; Lung disease; Prognosis; Pulmonary function; Rheumatoid arthritis; Risk factors

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG DIFFUSION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; UNITED KINGDOM; VITAL CAPACITY;

EID: 84906835347     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu165     Document Type: Article

References (42)

1. McDonagh J, Greaves M, Wright AR et al. High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol 1994;33:118-22.
2. Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography and pulmonary function tests. Thorax 2001;56:622-7.
3. Sokka T, Kautiainen H, Toloza S et al. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 2007;66:1491-6.
4. Bongartz T, Nannini C, Medina-Velasquez YF et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 2010;62:1583-91.
5. Young A, Koduri G, Batley M et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology 2007;46:350-7.
6. Sihvonen S, Korpela M, Laippala P, Mustonen J, Pasternack A. Death rates and causes of death in patients with rheumatoid arthritis: a population-based study. Scand J Rheumatol 2004;33:221-7.
7. Koduri G, Norton S, Young A et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort study. Rheumatology 2010;49: 1483-9.
8. Rajasekaran AB, Shovlin D, Lord P, Kelly CA. Interstitial lung disease in patients with rheumatoid arthritis; a comparison with cryptogenic fibrosing alveolitis. Rheumatology 2001;40:1022-5.
9. Weyand CM, Schmidt D, Wagner U et al. The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum 1998;41:817-22.
10. Linn-Rasker SP, van der Helm-van Mil AHM, van Gaalen FA et al. Smoking is a risk factor for anti-CCP antibodies only in RA patients that carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 2005;52:3058-62.
11. Oliver JE, Silman AJ. Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol 2006;35:169-74.
12. Saag KG, Cerhan JR, Kolluri S et al. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis 1997;56: 463-9.
13. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. A gene environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004;50: 3085-92.
14. Alexiou I, Germenis A, Koutroumpas A et al. Anti-cyclic citrullinated peptide (CCP) antibodies and extra articular manifestations in Greek patients with rheumatoid arthritis. Clin Rheumatol 2008;27:511-3.
15. Nannini C, Ryu JH, Matteson EL. Lung disease in rheumatoid arthritis. Curr Opin Rheumatol 2008;20:340-6.
16. Inui N, Enomoto N, Suda T et al. Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis. Clin Biochem 2008;41:1074-77.
17. Gabbay E, Tarala R, Will R et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997;156:528-35.
18. Lee HK, Lim DS, Yoo B et al. Histologic pattern and clinical features of rheumatoid arthritis associated interstitial lung disease. Chest 2005;127:2019-27.
19. Hyun-Kyung L, Dong-Soon K, Bin Y et al. Histopathologic pattern and clinical features of rheumatoid arthritisassoiated interstitial lung disease. Chest 2005;127: 2019-27.
20. Kim EJ, Elicker BM, Maldonado F et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010;35:1322-8.
21. Park JH, Kim DS, Park IN et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007;175:705-11.
22. Sathi N, Urwin T, Desmond S, Dawson J. Patients with limited rheumatoid arthritis-related interstitial lung disease have a better prognosis than those with extensive disease. Rheumatology 2011;50:620.
23. Aletaha D, Neogi T, Silman AJ et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-8.
24. De Lauretis A, Veeraraghavan S, Renzoni E. Connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? Chron Respir Dis 2011;8:53-82.
25. Nielen MMJ, Van Schaardenburg D, Reesink HW et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380-6.
26. Fischer A, Solomon JJ, du Bois RM et al. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med 2012;106: 1040-7.
27. Gizinski AM, Mascolo M, Loucks JL et al. Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA. Clin Rheumatol 2009;28:611-3.
28. Reynisdottir G, Nyren S, Harju A et al. Lung changes detected by high resolution tomography are present in ACPA positive RA patients already at disease onset [abstract]. Arthritis Rheum 2011;63(Suppl 10):2176.
29. Hassan WU, Keaney NP, Holland CD, Kelly CA. High resolution computed tomography of the lung in lifelong non-smoking patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:308-10.
30. Hayakawa H, Sato A, Imokawa S et al. Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med 1996;154:1531-6.
31. Demoruelle M, Weisman M, Derber L et al. Lung abnormalities in subjects with elevations of rheumatoid arthritis-related autoantibodies without arthritis by examination and imaging suggest the lung is an early and perhaps initiating site of inflammation in rheumatoid arthritis. Arthritis Rheum 2011;63(Suppl 10):769.
32. Manfredsdottir VF, Vikingsdottir T, Jonsson T et al. The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology 2006;45:734-40.
33. Masdottir B, Jonsson T, Manfredsdottir VF et al. Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis. Rheumatology 2000;39:1202-5.
34. Klareskog L, Stolt P, Lundberg K et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46.
35. Makrygiannakis D, Hermansson M, Ulfgren AK et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008;67:1488-92.
36. Tanaka N, Kim JS, Newell JD et al. Rheumatoid arthritisrelated lung diseases: CT findings. Radiology 2004;232: 81-91.
37. Hunninghake GW, Lynch DA, Galvin JR et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003;124: 1215-23.
38. Hartman TE, Swensen SJ, Hansell DM et al. Nonspecific interstitial pneumonia: variable appearance at highresolution chest CT. Radiology 2000;217:701-5.
39. MacDonald SL, Rubens MB, Hansell DM et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001;221:600-5.
40. Malik S, Saravanan V, Kelly CA. Interstitial lung disease in rheumatoid arthritis: an update on diagnosis and management. Int J Clin Rheum 2012;7:297-306.
41. Castelino FV, Goldberg H, Dellaripa PF. The impact of rheumatological evaluation in the management of patients with interstitial lung disease. Rheumatology 2011;50: 489-93.
42. Olson AL, Swigris JJ, Sprunger DB et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med 2011;183:372-8.